These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 6425086
1. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin) treatment in infertile patients with premature luteinization. Zimmermann R, Bohnet HG, Weise HC, Leidenberger FA. Fertil Steril; 1984 May; 41(5):714-8. PubMed ID: 6425086 [Abstract] [Full Text] [Related]
2. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. Messinis IE, Bergh T, Wide L. Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249 [Abstract] [Full Text] [Related]
5. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Olson JL, Rebar RW, Schreiber JR, Vaitukaitis JL. Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386 [Abstract] [Full Text] [Related]
6. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization. Jiang S, Kuang Y. Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429 [Abstract] [Full Text] [Related]
7. Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease. Evron S, Navot D, Laufer N, Diamant YZ. Fertil Steril; 1983 Aug; 40(2):183-6. PubMed ID: 6409672 [Abstract] [Full Text] [Related]
11. Induction of ovulation with luprolide acetate and human menopausal gonadotropin. Lewinthal D, Taylor PJ, Pattinson HA, Corenblum B. Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242 [Abstract] [Full Text] [Related]
15. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Cohen JJ, Debache C, Pigeau F, Mandelbaum J, Plachot M, de Brux J. Fertil Steril; 1984 Sep; 42(3):360-5. PubMed ID: 6432585 [Abstract] [Full Text] [Related]
17. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU). Gerris J, De Vits A, Joostens M, Van Royen E. Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071 [Abstract] [Full Text] [Related]
18. Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles. Gersak K, Tomazevic T. J Assist Reprod Genet; 1999 Oct; 16(9):488-91. PubMed ID: 10530403 [Abstract] [Full Text] [Related]
19. Preferred treatment of infertile women older than 37 years of age who demonstrate premature luteinization in the first evaluation cycle. Lidor AL, Cohen SB, Seidman DS, Mashiach S, Lipitz S, Goldenberg M. Fertil Steril; 2000 Feb; 73(2):321-4. PubMed ID: 10685536 [Abstract] [Full Text] [Related]